Fingerprint
Dive into the research topics of 'Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Mesenchymal stem cell treatment improves outcome of COVID-19 patients via multiple immunomodulatory mechanisms
Rongjia Zhu, Tingdong Yan, Yingmei Feng, Yan Liu, Hongcui Cao, Gongxin Peng, Yanlei Yang, Zhen Xu, Jingqi Liu, Wei Hou, Xiaoyue Wang, Zhe Li, Luchan Deng, Shihua Wang, Jing Li, Qin Han, Hongling Li, Guangliang Shan, Yinghao Cao, Xingyan An
*Corresponding author for this work
- Chinese Academy of Medical Sciences
- Shanghai University
- Capital Medical University
- Wuhan University of Science and Technology
- Zhejiang University
- National Clinical Research Center for Infectious Diseases
- Versiti Blood Research Institute
- CAS - Shanghai Institute of Nutrition and Health
- Ltd.
- International Society on Aging and Disease
- Bar-Ilan University
- Université Côte d'Azur
- Centre Hospitalier Universitaire (CHU)
- The University of Hong Kong
- RAS - Institute of Biology of the Komi Science Centre, Ural Branch
- Russian Gerontological Research Clinical Center
- University of Valencia
- Maharishi Markandeshwar University, Mullana
- Karolinska Institutet
- Institute of Chinese Medical Sciences
- Tsinghua University
- University of North Dakota
- Inha University
- King's College London
- University of Palermo
- University of North Texas Health Science Center
Research output: Contribution to journal › Article › peer-review
92
Citations
(Scopus)